Abstract: The present invention provides compounds and methods targeting human interleukin-19, including therapeutic antibodies, pharmaceutical compositions and methods of use thereof, useful in the field of immune-mediated diseases including psoriasis, atopic dermatitis, asthma, psoriatic arthritis, rheumatoid arthritis, axial spondyloarthritis, inflammatory bowel disease and colitis.
| # | Name | Date |
|---|---|---|
| 1 | 202417088924-STATEMENT OF UNDERTAKING (FORM 3) [18-11-2024(online)].pdf | 2024-11-18 |
| 3 | 202417088924-Sequence Listing in PDF [18-11-2024(online)].pdf | 2024-11-18 |
| 4 | 202417088924-REQUEST FOR EXAMINATION (FORM-18) [18-11-2024(online)].pdf | 2024-11-18 |
| 5 | 202417088924-POWER OF AUTHORITY [18-11-2024(online)].pdf | 2024-11-18 |
| 6 | 202417088924-FORM-26 [18-11-2024(online)].pdf | 2024-11-18 |
| 7 | 202417088924-FORM 18 [18-11-2024(online)].pdf | 2024-11-18 |
| 8 | 202417088924-FORM 1 [18-11-2024(online)].pdf | 2024-11-18 |
| 9 | 202417088924-DRAWINGS [18-11-2024(online)].pdf | 2024-11-18 |
| 10 | 202417088924-DECLARATION OF INVENTORSHIP (FORM 5) [18-11-2024(online)].pdf | 2024-11-18 |
| 11 | 202417088924-COMPLETE SPECIFICATION [18-11-2024(online)].pdf | 2024-11-18 |
| 12 | 202417088924-FORM 3 [16-01-2025(online)].pdf | 2025-01-16 |
| 13 | 202417088924-Proof of Right [06-05-2025(online)].pdf | 2025-05-06 |